Lomitapide Shows Promise in Pediatric Homozygous FH
Children and adolescents with homozygous familial hypercholesterolemia could benefit from lomitapide therapy, suggests a trial, although safety concerns and upcoming novel drugs question its place.
Medscape Medical News
source https://www.medscape.com/viewarticle/992523?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/992523?src=rss
Comments
Post a Comment